14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NLSP
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in NLS Pharmaceutics AG stock price on Monday moving 35.58% between high and low
(Updated on Jun 17, 2024)

Buy candidate since Jun 17, 2024 PDF

The NLS Pharmaceutics AG stock price gained 30.20% on the last trading day (Monday, 17th Jun 2024), rising from $0.114 to $0.148. During the last trading day the stock fluctuated 35.58% from a day low at $0.113 to a day high of $0.153. The price has fallen in 7 of the last 10 days but is still up by 9.04% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 12 million more shares were traded than the day before. In total, 12 million shares were bought and sold for approximately $1.85 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.73% during the next 3 months and, with a 90% probability hold a price between $0.0791 and $0.130 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NLSP Signals & Forecast

The NLS Pharmaceutics AG stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.126 and $0.144. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 14, 2024, and so far it has risen 30.20%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for NLS Pharmaceutics AG stock

NLS Pharmaceutics AG finds support from accumulated volume at $0.141 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0401 between high and low, or 35.58%. For the last week, the stock has had daily average volatility of 16.09%.

Our recommended stop-loss: $0.140 (-5.64%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 19 days ago.)

Trading Expectations (NLSP) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect NLS Pharmaceutics AG to open at $0.138, and during the day (based on 14 day Average True Range), to move between $0.128 and $0.169, which gives a possible trading interval of +/-$0.0205 (+/-13.82%) up or down from last closing price. If NLS Pharmaceutics AG takes out the full calculated possible swing range there will be an estimated 27.64% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.141 (4.92%) than the resistance at $0.157 (5.87%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NLS Pharmaceutics AG stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.510 Buy Candidate Upgraded

Predicted Opening Price for NLS Pharmaceutics AG of Tuesday, June 18, 2024

Fair opening price June 18, 2024 Current price
$0.138 ( 6.99%) $0.148

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NLSP

Fibonacci Support & Resistance Levels

Level Price
R3 0.178 20.05%
R2 0.163 9.72%
R1 0.153 3.34%
Price 0.148
S1 0.123 -17.32%
S2 0.113 -23.70%
S3 0.0978 -34.03%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.175 17.67%
R2 0.174 17.33%
R1 0.157 5.87%
Price 0.148
S1 0.141 -4.92%
S2 0.136 -8.29%
S3 0.131 -11.60%

FAQ

What is the symbol for NLS Pharmaceutics AG Stock and on which exchange is it traded?
The symbol for NLS Pharmaceutics AG is NLSP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NLS Pharmaceutics AG Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy NLS Pharmaceutics AG Stock?
NLS Pharmaceutics AG Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NLS Pharmaceutics AG Stock.

What's the current price of NLS Pharmaceutics AG Stock?
As of the end of day on the Jun 17, 2024, the price of an NLS Pharmaceutics AG (NLSP) share was $0.148.

What is the 52-week high and low for NLS Pharmaceutics AG Stock?
The 52-week high for NLS Pharmaceutics AG Stock is $1.53 and the 52-week low is $0.111.

What is the market capitalization of NLS Pharmaceutics AG Stock?
As of the Jun 17, 2024, the market capitalization of NLS Pharmaceutics AG is 6.434M.
Click to get the best stock tips daily for free!

About NLS Pharmaceutics AG

NLS Pharmaceutics AG NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to ... NLSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT